Contrast-enhanced MR imaging assessment of tumor capillary permeability: Effect of irradiation on delivery of chemotherapy

Radiology

Volumn 198, Issue 3, 1996, Pages 893-898

  Schwickert, Heidi C ^a,c   Stiskal, Michael ^a   Roberts, Timothy P L ^a   Van Dijke, Cornelis F ^a   Mann, Jeffry ^a   Mühler, Andreas ^b   Shames, David M ^a   Demsar, Franci ^a   Disston, Alexander ^a   Brasch, Robert C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BAYER PHARMA AG   (Germany)

^c UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Breast, neoplasms, therapy; Chemotherapy; Gadolinium; Magnetic resonance (MR), contrast enhancement; Neoplasms, blood supply; Neoplasms, MR; Neoplasms, therapy

Indexed keywords

CISPLATIN; GADOLINIUM PENTETATE ALBUMIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VOLUME; BREAST ADENOCARCINOMA; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CAPILLARY PERMEABILITY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DRUG TUMOR LEVEL; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIATION DOSE; RAT; TUMOR VASCULARIZATION; X IRRADIATION;

EID: 13344294380     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.198.3.8628889     Document Type: Article

References (70)

1. Jain RK. Barriers to drug delivery in solid tumors. Sci Am 1994; 271:58-65.
2. Jain RK. Delivery of novel therapeutic agents in tumors: physiological barriers and strategies. J Natl Cancer Inst 1989; 81: 570-576.
3. Seymour LW. Passive tumor targeting of soluble macromolecules and drug conjugates. Crit Rev Ther Drug Carrier Syst 1992; 9:135-187.
4. Maeda H, Seymour LW, Miyamoto Y. Conjugates of anticancer agents and polymers: advantages of macromolecular therapeutics in vivo. Bioconjugate Chem 1992; 3:351-362.
5. Aicher KP, Dupon JW, White DL, et al. Contrast-enhanced magnetic resonance imaging of tumor-bearing mice treated with human recombinant tumor necrosis factor a. Cancer Res 1990; 50:7376-7381.
6. Denekamp J. Vascular endothelium as the vulnerable element in tumours. Acta Radiol (Oncol) 1984; 23:217-225.
7. Dvorak HF, Nagy JA, Dvorak JT, Dvorak AM. Identification and characterization of the blood vessels of solid tumors that are leaky to circulating macromolecules. Am J Pathol 1988; 133:95-109.
8. Gerlowski LE, Jain RK. Microvascular permeability of normal and neoplastic tissues. Microvasc Res 1986; 31:288-305.
9. Gusterson BA, Warburton MJ, Mitchell D, Ellison M, Neville AM, Rudland PS. Distribution of myoepithelial cells and basement membrane proteins in the normal breast and in benign and malignant breast diseases. Cancer Res 1982; 42:4763-4770.
10. Jain RK. Transport of molecules across tumor vasculature. Cancer Metastasis Rev 1987; 6:559-569.
11. Parish CR, Jakobsen KB, Coombe DR. A basement-membrane permeability assay which correlates with the metastatic potential of tumor cells. Int J Cancer 1992; 52: 378-383.
12. Peterson HI, Appelgren KL, Lundborg G, Rosengren BHO. Capillary permeability of two transplantable rat tumors as compared with various normal organs of the rat. Proceedings of the 7th European Conference on Microcirculation, Aberdeen, Scotland, 1972; 12:511-518.
13. Peterson HI, Appelgren KL, Rosengren BHO. Experimental studies on the mechanisms of fibrinogen uptake in a rat tumour. Eur J Cancer 1972; 8:677-681.
14. Wikström MG, Moseley ME, White DL, et al. Contrast-enhanced MRI of tumors: comparison of Gd-DTPA and a macromolecular agent. Invest Radiol 1989; 24:609-615.
15. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma. New Engl J Med 1991; 324:1-8.
16. Folkman J. Tumor angiogenesis. Adv Cancer Res 1985; 43:175-199.
17. Cohen FM, Kuwatsuru R, Shames DM, et al. Contrast-enhanced magnetic resonance imaging estimation of altered capillary permeability in experimental mammary carcinomas after x-irradiation. Invest Radiol 1994; 29:970-977.
18. Eddy HA, Chmielewski G. Effect of hyperthermia, radiation, and adriamycin combinations on tumor vascular function. Int J Radial Oncol Biol Phys 1982: 8:1167-1175.
19. Evans ML, Graham MM, Mahler PA, Rasey JS. Changes in vascular permeability following thorax irradiation in the rat. Radiat Res 1986; 107:262-271.
20. Evans ML, Graham MM, Mahler PA, Rasey JS. Use of steroids to suppress vascular response to radiation. Int J Radiat Oncol Biol Phys 1987; 13:563-567.
21. Law MP, Thomlinson RH, Chir B. Vascular permeability in the ears of rats after x-irradiation, Br J Radiol 1978; 51:895-904.
22. Phillips TL, Benak S, Ross G. Ultrastructural and cellular effects of ionizing radiation. Frontiers Radiat Ther Oncol 1972; 6:21-43.
23. Song CW, Drescher JJ, Tabachnick J. Effect of anti-inflammatory compounds on beta-irradiation-induced increase in vascular permeability. Radiat Res 1968; 34:616-625.
24. Withers HR, Peters LJ, Kogelnik HD. The pathobiology of late effects of irradiation. In: Meyn RE, Withers HR, eds. Radiation biology in cancer research. New York, NY: Raven, 1980; 439-449.
25. Halverson KJ, Perez CA, Kuske RR, Garcia DM, Simpson JR, Fineberg B. Locoregional recurrence of breast cancer: a retrospective comparison of irradiation alone versus irradiation and systemic therapy. Am J Clin Oncol 1992; 15:93-101.
26. Wong HH, Song CW, Levitt SH. Early changes in the functional vasculature of Walker carcinoma 256 following irradiation. Radiology 1973; 108:429-434.
27. Ackerman NB, Hechmer PA. Studies on the capillary permeability of experimental liver metastases. Surg Gynecol Obstet 1978; 146:884-888.
28. Pronzato P, Miglietta L, Rubagotti A, et al. Impact of irradiation of residual breast on adjuvant chemotherapy dose intensity. Am J Clin Oncol 1993; 16:58-60.
29. Ahmann DL, O'Fallon JR, Scanlon PW, et al. A preliminary assessment of factors associated with recurrent disease in a surgical adjuvant clinical trial for patients with breast cancer with special emphasis on the aggressiveness of therapy. Am J Clin Oncol 1982; 5:371-381.
30. Recht A, Come SE, Gelman RS, et al. Integration of conservative surgery, radiotherapy, and chemotherapy for the treatment of early-stage, node-positive breast cancer: sequencing, timing, and outcome. J Clin Oncol 1991; 9:1662-1667.
31. Buzdar AU, McNeese MD, Hortobagyi GN, et al. Is chemotherapy effective in reducing the local failure rate in patients with operable breast carcinoma? Cancer 1990; 65:394-399.
32. Brasch R. New directions in the development of MR imaging contrast media. Radiology 1992; 183:1-11.
33. Shames D, Kuwatsuru R, Vexler V, Mühler A, Brasch RC. Measurement of capillary permeability to macromolecules by dynamic magnetic resonance imaging: a quantitative noninvasive technique. Magn Reson Med 1993; 29:616-622.
34. Kuwatsuru R, Shames DM, Mühler A. Quantification of tissue plasma volume in the rat by contrast-enhanced magnetic resonance imaging. Magn Reson Med 1993; 30:76-81.
35. Hilf R, Freeman JJ, Michel I, Borman A. Characterization of a transplantable lactating mammary tumor: endocrinological, morphological, and biochemical aspects. Cancer Res 1964; 24:812-823.
36. Bogden AE. Therapy in experimental breast cancer models. In: McGuire WL, ed. Breast cancer. Vol 2. Advances in research and treatment - experimental biology. New York, NY: Plenum Medical, 1989; 283-336.
37. Less JR, Skalak TC, Sevick EM, Jain RK. Microvascular architecture in a mammary carcinoma: branching patterns and vessel dimensions. Cancer Res 1991; 51:265-273.
38. Reimer P, Weissleder R, Nickeleit V, Brady TJ. Animal models for magnetic resonance imaging research of the liver. Invest Radiol 1992; 27:390-393.
39. Bogden AE, Taylor DJ. Predictive mammary tumor test systems for experimental chemotherapy. In: Heuson JC, Mattheiem WH, Rozenzweig M, eds. Breast cancer: trends in research and treatment. New York, NY: Raven, 1976; 95-110.
40. Ogan MD, Schmiedl U, Moseley ME, Grodd W, Paajanen H, Brasch RC. Albumin labeled with Gd-DTPA: an intravascular contrast-enhancing agent for magnetic resonance blood pool imaging - preparation and characterization. Invest Radiol 1987; 22:665-671.
41. Schmiedl U, Ogan M, Moseley ME, Brasch RC. Comparison of the contrast-enhancing properties of albumin-(Gd-DTPA) and Gd-DTPA at 2.0 T: an experimental study in rats. AJR 1986; 147:1263-1270.
42. Schmiedl U, Ogan M, Paajanen H. Albumin labeled with Gd-DTPA as an intravascular, blood pool-enhancing agent for MR imaging: biodistribution and imaging studies. Radiology 1987; 162:205-210.
43. 15-20: whole-body clearance, plasma clearance and organ distribution of gadolinium (abstr). In: Book of abstracts: Society of Magnetic Resonance in Medicine 1989. Berkeley, Calif: Society of Magnetic Resonance in Medicine, 1989; 807.
44. Niemi P, Koskinen S, Reisto T. Tissue relaxation enhancement after intravenous administration of (ITCB-DTPA)-gadolinium conjugated albumin, an intravascular magnetic resonance imaging contrast agent. Invest Radiol 1991; 26:674-678.
45. 3+. Magn Reson Imaging 1992; 10:913-917.
46. Tofts PS, Kermode AG. Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. I. Fundamental concepts. Magn Reson Med 1991; 17:357-367.
47. Patlak CS, Goldstein DA, Hoffman JF. The flow of solute and solvent across a two-membrane system. J Theoretical Biol 1963; 5:426-442.
48. Perera A, Jackson H, Sharma HS, McAuliffe CA, Fox BW. A comparative binding of platinum anti-tumour compounds to plasma proteins in the rat (in vivo) and mouse (in vitro). Chem Biol Interact 1992; 85:199-213.
49. Riley CM, Sternson LA, Repta AF. High-performance liquid chromatography of cisplatin. J Pharm Sci 1983; 72:351-355.
50. Eksborg A, Ehrsson H, Ekquist B. Protein binding of anthraquinone glycosides with special reference to adriamycin. Cancer Chemother Pharmacol 1982; 10:7-10.
51. Steele W, King DJ, Barber HE, Hawksworth GM, Dawson AA, Petric JC. The protein binding of vinblastine in the serum of normal subjects and patients with Hodgkin's disease. Eur J Clin Pharmacol 1983; 24:683-687.
52. DeConti RC, Toftness BR, Lange RC, Creasey WA. Clinical and pharmacological studies with cis-diaminedichloroplatinum (II). Cancer Res 1973; 33:1310-1315.
53. Shibata S, Jinnouchi T, Mori K. Ultrastructural study of capillary permeability of liposome-encapsulated cisplatin in an experimental rat brain tumor model. Neurol Med Chir (Tokyo) 1989; 29:696-700.
54. Manaka RC, Wolf W. Distribution of cisplatin in blood. Chem-Biol Interact 1978; 22:353-358.
55. Fassel V. Simultaneous or sequential determination of the elements at all concentration levels: the renaissance of an old approach. Anal Chem 1979; 51(suppl A): 1290A-1308A.
56. Song CW, Levitt SH. Quantitative study of vascularity in Walker carcinoma 256. Cancer Res 1971; 31:587-589.
57. Song CW, Levitt SH. Vascular changes in Walker 256 carcinoma of rats following x-irradiation. Radiology 1971; 100:397-407.
58. Song CW, Payne JT, Levitt SH. Vascularity and blood flow in x-irradiated Walker carcinoma 256 of rats. Radiology 1972; 104: 693-697.
59. Eassa EHM, Casarett GW. Effect of epsilon-amino-n caproic acid (EACA) on radiation-induced increase in capillary permeability. Radiology 1973; 106:679-688.
60. Krishnan L, Krishnan EC, Jewell WR. Immediate effect of irradiation on microvasculature. Int J Radiat Oncol Biol Phys 1988; 15:147-150.
61. Eriksson B, Johnson L, Lundquist PG. Ultrastructural aspects of capillary function in irradiated bowel. Scand J Gastroenterol 1983; 18:473-480.
62. Jain RK. Transport of molecules in the tumor interstitium: a review. Cancer Res 1987; 47:3039-3051.
63. Andrasi E, Nadasdi J, Molnar Z, Bezur L, Ernyei L. Determination of main and trace element contents in human brain by NAA and ICP-AES methods. Biol Trace Element Res 1990; 691-698.
64. Smith IE, Talbot DC. Cisplatin and its analogues in the treatment of advanced breast cancer: a review. Br J Cancer 1992; 65:787-793.
65. Adam G, Neuerburg J, Spüntrup E, Mühler A, Scherer K, Günther RW. Dynamic contrast-enhanced MR imaging of the upper abdomen: enhancement properties of gadobutrol, gadolinium-DTPA-polylysine, and gadolinium-DTPA-cascade-polymer. Magn Reson Med 1994; 32:622-628.
66. Dewhirst MW, Oliver R, Tso CY, Gustafson C, Secomb T, Gross JF. Heterogeneity in tumor microvascular response to radiation. Int J Radiat Oncol Biol Phys 1990; 18:559-568.
67. Choi KN, Rotman M, Aziz H, Potters L, Stark R, Rosenthal CJ. Locally advanced paranasal sinus and nasopharynx rumors treated with hyperfractionated radiation and concomitant infusion cisplatin. Cancer 1991; 67:2748-2752.
68. Douple EB, Richmond RC, Logan ME. Therapeutic potentiation in a mouse mammary tumor and an intracerebral rat brain tumor by combined treatment with cis-dichlorodiamineplatinum (II) and radiation. J Clin Hematol Oncol 1977; 7:585-603.
69. Dritschillo A, Piro AJ, Kelman AD. The effect of cis-platinum on the repair of radiation damage in plateau phase Chinese hamster (V-79) cells. Int J Radiat Oncol Biol Phys 1979; 5:1345-1349.
70. Coughlin CT, Richmond RC. Biologic and clinical developments of cisplatinum combined with radiation: concepts, utility, projections for new trials, and the emergence of carboplatin. Semin Oncol 1989; 16(suppl 6):31-43.